Skip to main content

CORRECTION article

Front. Immunol., 08 February 2023
Sec. Vaccines and Molecular Therapeutics

Corrigendum: Bioinformatics analysis and consistency verification of a novel tuberculosis vaccine candidate HP13138PB

Peng Cheng,&#x;Peng Cheng1,2†Fan Jiang&#x;Fan Jiang3†Guiyuan Wang,&#x;Guiyuan Wang1,4†Jie WangJie Wang1Yong XueYong Xue1Liang Wang*Liang Wang2*Wenping Gong*Wenping Gong1*
  • 1Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The Eighth Medical Center of PLA General Hospital, Beijing, China
  • 2Department of Geriatrics, The Eighth Medical Center of PLA General Hospital, Beijing, China
  • 3The Second Brigade of Cadet, Basic Medical School, Air Force Military Medical University, Xi’an, Shaanxi, China
  • 4Hebei North University, Zhangjiakou, Hebei, China

A Corrigendum on
Bioinformatics analysis and consistency verification of a novel tuberculosis vaccine candidate HP13138PB

by Cheng P, Jiang F, Wang G, Wang J, Xue Y, Wang L and Gong W (2023) Front. Immunol. 14:1102578. doi: 10.3389/fimmu.2023.1102578

In the published article, there was an error in Figure 2A as published. The “H13132” should be changed to “HP13138PB” in the Figure 2A. The corrected Figure 2 and its caption “Figure 2. (A) The molecular solubility of the HP13138PB vaccine was predicted by the Protein-Sol server. (B) The secondary structure of the HP13138PB vaccine” appear below.

FIGURE 2
www.frontiersin.org

Figure 2 (A) The molecular solubility of the HP13138PB vaccine was predicted by the Protein-Sol server. (B) The secondary structure of the HP13138PB vaccine.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: tuberculosis, epitope vaccines, immunoinformatics, immune responses, bioinformatics

Citation: Cheng P, Jiang F, Wang G, Wang J, Xue Y, Wang L and Gong W (2023) Corrigendum: Bioinformatics analysis and consistency verification of a novel tuberculosis vaccine candidate HP13138PB. Front. Immunol. 14:1154693. doi: 10.3389/fimmu.2023.1154693

Received: 31 January 2023; Accepted: 02 February 2023;
Published: 08 February 2023.

Edited and Reviewed by:

Filippo Castiglione, Technology Innovation Institute (TII), United Arab Emirates

Copyright © 2023 Cheng, Jiang, Wang, Wang, Xue, Wang and Gong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Wenping Gong, gwp891015@whu.edu.cn; Liang Wang, Wangl309@sina.com

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.